Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

STERIS plc (STE) Stock Falls on Q3 2026 Earnings

None

STERIS plc (STE) reported third-quarter 2026 results with total revenue of $1.46 billion, up 6.55% year-over-year. The company posted improvements across profitability metrics, including gross profit of $645.9 million (+5.83% YoY) and operating profit of $265.8 million (+8.36% YoY). Net income attributable to common shareholders rose to $191.9 million (+10.58% YoY), and diluted earnings per share came in at $1.94 (+10.86% YoY).

  • Revenue: $1.46 billion (+6.55% YoY)
  • Gross profit: $645.9 million (+5.83% YoY)
  • Operating profit: $265.8 million (+8.36% YoY)
  • Cost of sales: $814.4 million (+7.12% YoY)
  • Net income: $191.9 million (+10.58% YoY)
  • On the cash-flow and balance-sheet front, operating cash flow declined year-over-year while liquidity improved. Cash from operating activities was $298.2 million (down 10.4% YoY), and the company invested $98.7 million in property, plant and equipment. Cash and cash equivalents rose to $319.2 million (up 105.7% YoY), while total liabilities fell to $3.39 billion (down 5.35% YoY).

  • Cash from operations: $298.2 million (-10.4% YoY)
  • Capital expenditures: $98.7 million (+10.64% YoY)
  • Cash and equivalents: $319.2 million (+105.7% YoY)
  • Total liabilities: $3.39 billion (-5.35% YoY)
  • Results compared with analyst expectations showed revenue and EPS below estimates. Consensus revenue was about $1.50 billion, and the EPS estimate was roughly $2.56; the stock reacted with a decline of 2.48% since market close.

  • Revenue estimate: $1.50 billion
  • EPS estimate: $2.56
  • Stock change since close: -2.48%
  • Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

    STERIS plc Insider Trading Activity

    STE Insider Trades

    STERIS plc insiders have traded $STE stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.

    Here’s a breakdown of recent trading of $STE stock by insiders over the last 6 months:

    • JOHN ADAM ZANGERLE (Sr. VP, Gen Counsel, and Sec.) sold 15,000 shares for an estimated $3,977,100
    • RENATO TAMARO (V.P. & Corporate Treasurer) has made 0 purchases and 4 sales selling 8,240 shares for an estimated $2,095,604.
    • KAREN L BURTON (VP & CAO) sold 7,900 shares for an estimated $1,909,667
    • JULIA MADSEN (Sr. VP and GM, Life Sciences) has made 0 purchases and 2 sales selling 5,008 shares for an estimated $1,312,096.
    • MOHSEN SOHI sold 4,110 shares for an estimated $994,455
    • CYNTHIA L FELDMANN sold 3,495 shares for an estimated $844,252
    • DANIEL A CARESTIO (President and CEO) sold 159 shares for an estimated $38,449

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    STERIS plc Hedge Fund Activity

    We have seen 432 institutional investors add shares of STERIS plc stock to their portfolio, and 396 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    STERIS plc Congressional Stock Trading

    Members of Congress have traded $STE stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

    Here’s a breakdown of recent trading of $STE stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles